Target-induced death by apoptosis in human lymphokine-activated natural killer cells

Blood

Volumn 87, Issue 6, 1996, Pages 2411-2418

  Taga, Kazuyuki ^a   Yamauchi, Akira ^a   Kabashima, Kenji ^a   Bloom, Eda T ^a   Muller, Jacqueline ^a   Tosato, Giovanna ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; ARTICLE; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; CYTOLYSIS; HUMAN; HUMAN CELL; LIGAND BINDING; LYMPHOCYTE ACTIVATION; LYMPHOKINE ACTIVATED KILLER CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; TARGET CELL;

EID: 0029919009     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.6.2411.bloodjournal8762411     Document Type: Article

References (44)

1. Raff MC: Social controls on cell survival and cell death. Nature 356:397, 1992
2. Raff MC, Barres BA, Burne JF, Coles HS, Ishizaki Y, Jacobson MD: Programmed cell death and the control of cell survival: Lessons from the nervous system. Science 262:695, 1993
3. Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T: p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362:847, 1993
4. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML, Wylie AH: Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362:849, 1993
5. Wylie AH, Morris RG, Smith AL, Dunlop D: Chromatin cleavage in apoptosis association with condensed chromatin morphology and dependence on macromolecular synthesis. J Pathol 142:67, 1984
6. Cohen JJ: Programmed cell death in the immune system. Adv Immunol 50:55, 1991
7. Golstein P, Ojcius DM, Young JDE: Cell death mechanisms and the immune system. Immunol Rev 121:29, 1991
8. Smith CA, Williams GT, Kingston R, Jenkinson EJ, Owen JJT: Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature 337:181, 1989
9. Shi Y, Bissonnette RP, Parfrey N, Szalay M, Kubo RT, Green DR: In vivo administration of monoclonal antibodies to the CD3 T cell receptor complex induces cell death (apoptosis) in immature thymocytes. J Immunol 146:3340, 1991
10. Kappler JW, Roehm N, Marrack P: T cell tolerance by clonal elimination in the thymus. Cell 49:273, 1987
11. Lenardo MJ: Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis. Nature 353:858, 1991
12. Boehme SA, Lenardo MI: Ligand-induced apoptosis of mature T lymphocytes (propriocidal regulation) occurs at distinct stages of the cell cycle. Leukemia 7:S45, 1993
13. Boehme SA, Lenardo MJ: Propriocidal apoptosis of mature T lymphocytes occurs at S phase of the cell cycle. Eur J Immunol 23:1552, 1993
14. Osmond DG: Population dynamics of bone marrow B lymphocytes. Immunol Rev 93:103, 1986
15. Liu YI, Joshua DE, Williams GT, Smith CA, Gordon J, McLennan IC: Mechanism of antigen-derived selection in germinal centres. Nature 342:929, 1989
16. Krammer PH, Behrmann I, Bier V, Daniel P, Dhein J, Falk MH, Garcin G, Klas C, Lucking-Famira KM, Matzku S, Oehm A, Richards S, Trauth BC, Bornkamm GW, Falk W, Moller P, Debatin KM: Apoptosis in the APO-1 system, in Tomei J, Cope F (eds): Apoptosis: The Molecular Basis of Cell Death. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1991 p 87
17. Ortaldo JR, Mason AT, O'Shea JJ: Receptor-induced death in human natural killer cells: Involvement of CD16. J Exp Med 181:339, 1995
18. Azzoni L, Anegon I, Calabretta B, Perussia B: Ligand binding to FcγR induces c-myc-dependent apoptosis in IL-2-stimulated NK cells. J Immunol 154:491, 1995
19. Yamauchi A, Bloom ET: Requirement of thiol compounds as reducing agents for IL-2-mediated induction of LAK activity and proliferation of human NK cells. J Immunol 151:5535, 1993
20. Duke RC, Cohen JJ: Morphological and biological assays of apoptosis, in Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W (eds): Current Protocols in Immunology. New York, NY, Greene/Wiley-Interscience, 1992, Unit 3.17; 1-16
21. Kazuyuki T, Chretien J, Cherney B, Diaz L, Brown M, Tosato G: Interleukm-10 inhibits apoptotic cell death in infectious mononucleosis T cells. J Clin Invest 94:251, 1994
22. Matzinger P: The JAM test. A simple assay for DNA fragmentation and cell death. J Immunol Methods 145:185, 1991
23. Ferrarini M, Grossi CE: Ultrastructure and cytochemistry of human large granular lymphocytes, in Lotzova E, Herberman RB (eds): Immunobiology of Natural Killer Cells, vol 1. Boca Raton, FL, CRC Inc, p 33
24. Trinchieri G: Biology of natural killer cells. Adv Immunol 47:187, 1989
25. Stahls A, Heiskala M, Mustelin T, Andersson LC: Activation of natural killer cells via the FcγRIII (CD16) requires initial tyrosine phosphorilation. Eur J Immunol 22:611, 1992
26. Ashwell JD, Berger NA, Cidlowski JA, Lane DP, Korsmeyer SJ: Coming to terms with death: Apoptosis in cancer and immune development. Immunol Today 15:147, 1994
27. Debatin KM, Suss D, Krammer PH: Differential expression of APO-1 on human thymocytes: Implications for negative selection? Eur J Immunol 24:753, 1994
28. Migliorati G, Nicoletti I, D'Adamio F, Spreca A, Pagliacci C, Riccardi C: Dexamethasone induces apoptosis in mouse natural killer cells and cytotoxic T lymphocytes. J Immunol 81:21, 1994
29. Evan GI, Wylie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ, Hancock DC: Induction of apoptosis in fibroblasts by c-myc protein. Cell 69:119, 1992
30. Cherney BW, Bhatia K, Tosato G: A role for deregulated c-Myc expression in apoptosis of Epstein-Barr virus-immortalized B cells. Proc Natl Acad Sci USA 91:12967, 1994
31. Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A, Ore M: Wild-type p53 induces apoptosis of myeloid leukemic cells that is inhibited by interleukin-6. Nature 352:345, 1991
32. Marin MC, Hsu B, Meyn RE, Donehower LA, El-Naggar AK, McDonnell TJ: Evidence that p53 and bcl-2 are regulators of a common cell death pathway important for in vivo lymphomagenesis. Oncogene 9:3107, 1994
33. Vaux DL, Cory S, Adams J: Bcl-2 gene promotes hemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335:440, 1988
34. Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ: Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348:334, 1990
35. Sentman CL, Shutter JR, Hockenbery D, Kanagawa O, Korsmeyer SJ: Bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 67:879, 1991
36. Fanidi A, Harrington EA, Evan GI: Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature 359:554, 1992
37. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D: p21 is a universal inhibitor of cyclin kinases. Nature 366:701, 1993
38. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kanzler KW, Vogelstein B: WAF1, a potential mediator of p53 tumor suppression. Cell 75:817, 1993
39. 1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein. Proc Natl Acad Sci USA 91:5320, 1994
40. Miyawaki T, Uehara T, Nibu R, Tsuji T, Yachie A, Yonehara S, Taniguchi N: Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood. J Immunol 149:3753, 1992
41. Ullberg M, Jondal M: Recycling and target binding capacity of human natural killer cells. J Exp Med 153:615, 1981
42. Lebow LT, Jewett A, Bonavida B: Killer cell recruitment and renewal capacity of purified cytolytic and noncytolytic human peripheral blood natural killer cell subsets. J Immunol 150:320, 1993
43. Rosenberg SA, Yang JC, Topalian SL, Schwarzentruber DJ, Weber DR, Parkinson CA, Seipp CA, Einhorn JH, White DE: Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high dose bolus interleukin 2. JAMA 271:945, 1994
44. Sparano JA, Fisher RI, Sunderland M, Margolin K, Ernest ML, Sznol M, Atkins MB, Dutcher JP, Micetich KC, Weiss GR: Randomized phase III trial of treatment with high-dose interleukin-2 either alone or in combination with interferon alpha 2a in patients with advanced melanoma. J Clin Oncol 11:1969, 1993